Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Risk of fall in patients taking proton pump inhibitors: a meta-analysis.

Lapumnuaypol K, Thongprayoon C, Wijarnpreecha K, Tiu A, Cheungpasitporn W.

QJM. 2019 Feb 1;112(2):115-121. doi: 10.1093/qjmed/hcy245. No abstract available.

PMID:
30364990
2.

Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?

Sugiyama T, Watarai K, Oda T, Kim YT, Oda H.

Osteoporos Int. 2016 Apr;27(4):1675-1676. doi: 10.1007/s00198-016-3509-7. Epub 2016 Feb 9. No abstract available.

PMID:
26860500
3.

Association of Proton Pump Inhibitor Use with Recurrent Falls and Risk of Fractures in Older Women: A Study of Medication Use in Older Fallers.

Thaler HW, Sterke CS, van der Cammen TJ.

J Nutr Health Aging. 2016 Jan;20(1):77-81. doi: 10.1007/s12603-015-0512-1.

PMID:
26728937
4.

Delirium in the geriatric unit: proton-pump inhibitors and other risk factors.

Otremba I, Wilczyński K, Szewieczek J.

Clin Interv Aging. 2016 Apr 4;11:397-405. doi: 10.2147/CIA.S103349. eCollection 2016.

5.

Risk factors for falls with use of acid-suppressive drugs.

Cea-Soriano L, Johansson S, García Rodríguez LA.

Epidemiology. 2013 Jul;24(4):600-7. doi: 10.1097/EDE.0b013e318294bec6.

PMID:
23676267
6.

Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.

Lewis JR, Barre D, Zhu K, Ivey KL, Lim EM, Hughes J, Prince RL.

J Bone Miner Res. 2014 Nov;29(11):2489-97. doi: 10.1002/jbmr.2279.

7.

Proton pump inhibitors: Clostridium difficile infections.

[No authors listed]

Prescrire Int. 2013 Oct;22(142):239-40.

PMID:
24298587
8.

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.

Yu EW, Bauer SR, Bain PA, Bauer DC.

Am J Med. 2011 Jun;124(6):519-26. doi: 10.1016/j.amjmed.2011.01.007.

9.

Proton pump inhibitors: bacterial pneumonia.

[No authors listed]

Prescrire Int. 2012 Sep;21(130):210-2. Review.

PMID:
23016253
10.

Proton pump inhibitors and the risk of colorectal cancer: a meta-analysis.

Chen S, Song X, Gao X, Li M, Chen Z, He Y, Zhan W.

J Clin Gastroenterol. 2011 Feb;45(2):177. doi: 10.1097/MCG.0b013e3181ea181e. No abstract available.

PMID:
20697292
11.

People taking proton pump inhibitors may have increased risk of myocardial infarction, study shows.

Mayor S.

BMJ. 2015 Jun 11;350:h3220. doi: 10.1136/bmj.h3220. No abstract available.

PMID:
26066506
12.

Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.

Wijarnpreecha K, Thongprayoon C, Chesdachai S, Panjawatanana P, Ungprasert P, Cheungpasitporn W.

Dig Dis Sci. 2017 Oct;62(10):2821-2827. doi: 10.1007/s10620-017-4725-5. Epub 2017 Aug 23. Review.

PMID:
28836158
13.

What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?

Patel AJ, Som R.

Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):356-60. doi: 10.1093/icvts/ivs483. Epub 2012 Dec 2. Review.

14.

Proton pump inhibitor and clopidogrel interaction: the case for watchful waiting.

Tan VP, Yan BP, Hunt RH, Wong BC.

J Gastroenterol Hepatol. 2010 Aug;25(8):1342-7. doi: 10.1111/j.1440-1746.2010.06366.x. Review.

PMID:
20659222
15.

Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.

Kwok CS, Loke YK.

Aliment Pharmacol Ther. 2010 Apr;31(8):810-23. doi: 10.1111/j.1365-2036.2010.04247.x. Epub 2010 Jan 22. Review. Erratum in: Aliment Pharmacol Ther. 2010 Sep;32(5):696.

16.

Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors.

Valkhoff VE, 't Jong GW, Van Soest EM, Kuipers EJ, Sturkenboom MC.

Aliment Pharmacol Ther. 2011 Jan;33(1):77-88. doi: 10.1111/j.1365-2036.2010.04485.x. Epub 2010 Oct 19.

17.

Bone up on proton pump inhibitors and fracture risk.

Gendreau-Webb R.

Nursing. 2007 Oct;37(10):60-1. No abstract available.

PMID:
17906557
18.

Proton pump inhibitors therapy and risk of bone diseases: An update meta-analysis.

Liu J, Li X, Fan L, Yang J, Wang J, Sun J, Wang Z.

Life Sci. 2019 Feb 1;218:213-223. doi: 10.1016/j.lfs.2018.12.058. Epub 2018 Dec 31.

PMID:
30605646
19.

The possible risks of proton pump inhibitors.

Gracie DJ, Ford AC.

Med J Aust. 2016 Oct 3;205(7):292-3. No abstract available.

PMID:
27681962
20.

Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.

de Jager CP, Wever PC, Gemen EF, van Oijen MG, van Gageldonk-Lafeber AB, Siersema PD, Kusters GC, Laheij RJ.

Aliment Pharmacol Ther. 2012 Nov;36(10):941-9. doi: 10.1111/apt.12069. Epub 2012 Oct 3.

Supplemental Content

Support Center